Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxis.
Donnenberg
A D
AD
Bone Marrow Transplantation Program, Johns Hopkins University School of Medicine, Baltimore, MD.
Hess
A D
AD
Duff
S C
SC
Bright
E C
EC
Noga
S J
SJ
Rowley
S D
SD
Saral
R
R
Santos
G W
GW
D000917:Antibody Formation; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002469:Cell Separation; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008213:Lymphocyte Activation; D008775:Methylprednisolone / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000166:cytology
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone